The Company has formulated a plan to; 1) increase the market penetration of existing products into North America, 2) rapidly expand the product portfolio with quality reagents targeted to some of the fastest growing areas of research and 3) execute an acquisition strategy to create a high-value company with revenues in excess of $25 million.